T. Rowe Price Associates’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-128,228
Closed -$188K 3095
2022
Q2
$188K Sell
128,228
-12,869
-9% -$9.46K ﹤0.01% 2622
2022
Q1
$162K Buy
141,097
+83,839
+146% +$137K ﹤0.01% 2758
2021
Q4
$143K Sell
57,258
-36,900
-39% -$145K ﹤0.01% 2820
2021
Q3
$482K Sell
94,158
-160,208
-63% -$973K ﹤0.01% 2400
2021
Q2
$2.11M Sell
254,366
-685,865
-73% -$5.78M ﹤0.01% 1716
2021
Q1
$8.19M Sell
940,231
-602,356
-39% -$6.23M ﹤0.01% 1420
2020
Q4
$16.8M Sell
1,542,587
-42,465
-3% -$524K ﹤0.01% 1260
2020
Q3
$18.9M Sell
1,585,052
-442,195
-22% -$5.92M ﹤0.01% 1170
2020
Q2
$32.6M Buy
2,027,247
+645,097
+47% +$11.3M ﹤0.01% 988
2020
Q1
$21.4M Sell
1,382,150
-20,943
-1% -$450K ﹤0.01% 1049
2019
Q4
$34.5M Buy
1,403,093
+1,372,023
+4,416% +$20.4M ﹤0.01% 1028
2019
Q3
$320K Sell
31,070
-604,593
-95% -$7.63M ﹤0.01% 2259
2019
Q2
$7.98M Buy
635,663
+231,109
+57% +$2.97M ﹤0.01% 1350
2019
Q1
$5.01M Buy
+404,554
New +$4.52M ﹤0.01% 1398
2018
Q1
Sell
-359,512
Closed -$4.51M 2600
2017
Q4
$4.51M Buy
359,512
+344,800
+2,344% +$5.01M ﹤0.01% 1445
2017
Q3
$280K Hold
14,712
﹤0.01% 2303
2017
Q2
$222K Sell
14,712
-1,100
-7% -$16.6K ﹤0.01% 2340
2017
Q1
$271K Buy
15,812
+12
+0.1% +$160 ﹤0.01% 2298
2016
Q4
$191K Sell
15,800
-11,100
-41% -$116K ﹤0.01% 2393
2016
Q3
$265K Buy
26,900
+7,500
+39% +$68.5K ﹤0.01% 2263
2016
Q2
$199K Buy
19,400
+7,000
+56% +$78.1K ﹤0.01% 2333
2016
Q1
$150K Hold
12,400
﹤0.01% 2350
2015
Q4
$199K Buy
+12,400
New +$184K ﹤0.01% 2304
2014
Q4
Sell
-585,771
Closed -$15.9M 2572
2014
Q3
$15.9M Buy
585,771
+61,240
+12% +$1.9M ﹤0.01% 1179
2014
Q2
$16.3M Buy
+524,531
New +$12.4M ﹤0.01% 1171

Other funds holding EPZM